Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bariatric surgery and diabetes: who should be offered the option of remission?

Literature DB >> 19366781

Bariatric surgery and diabetes: who should be offered the option of remission?

Jonathan Q Purnell¹, David R Flum.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2009 PMID： 19366781 PMCID： PMC4220451 DOI： 10.1001/jama.2009.541

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

× No keyword cloud information.

11 in total

Review 1. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors:
Journal: Obes Res Date: 1998-09

2. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.

Authors: Bryan A Whitson; Daniel B Leslie; Todd A Kellogg; Michael A Maddaus; Henry Buchwald; Charles J Billington; Sayeed Ikramuddin
Journal: J Surg Res Date: 2007-07 Impact factor: 2.192

Review 3. Bariatric surgery: a systematic review and meta-analysis.

Authors: Henry Buchwald; Yoav Avidor; Eugene Braunwald; Michael D Jensen; Walter Pories; Kyle Fahrbach; Karen Schoelles
Journal: JAMA Date: 2004-10-13 Impact factor: 56.272

4. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.

Authors: John B Dixon; Paul E O'Brien; Julie Playfair; Leon Chapman; Linda M Schachter; Stewart Skinner; Joseph Proietto; Michael Bailey; Margaret Anderson
Journal: JAMA Date: 2008-01-23 Impact factor: 56.272

5. Increases in morbid obesity in the USA: 2000-2005.

Authors: R Sturm
Journal: Public Health Date: 2007-03-30 Impact factor: 2.427

6. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

Authors: Blandine Laferrère; Julio Teixeira; James McGinty; Hao Tran; Joseph R Egger; Antonia Colarusso; Betty Kovack; Baani Bawa; Ninan Koshy; Hongchan Lee; Kimberly Yapp; Blanca Olivan
Journal: J Clin Endocrinol Metab Date: 2008-04-22 Impact factor: 5.958

7. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis.

Authors: Francesco Rubino
Journal: Diabetes Care Date: 2008-02 Impact factor: 19.112

8. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery.

Authors: M Tarnoff; L Rodriguez; A Escalona; A Ramos; M Neto; M Alamo; E Reyes; F Pimentel; L Ibanez
Journal: Surg Endosc Date: 2008-12-06 Impact factor: 4.584

Review 9. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes.

Authors: Ele Ferrannini; Geltrude Mingrone
Journal: Diabetes Care Date: 2009-03 Impact factor: 19.112

10. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys.

Authors: H E Bays; R H Chapman; S Grandy
Journal: Int J Clin Pract Date: 2007-05 Impact factor: 2.503

5 in total

Bariatric surgery and diabetes: who should be offered the option of remission?

Review 1. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

2. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.

Review 3. Bariatric surgery: a systematic review and meta-analysis.

4. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.

5. Increases in morbid obesity in the USA: 2000-2005.

6. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

7. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis.

8. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery.

Review 9. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes.

10. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys.

Review 1. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes.

Review 2. Inflammation, obesity, and the promise of immunotherapy for metabolic disease.

3. Bariatric surgery for type 2 diabetes reversal: the risks.

4. Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.

5. Morbidly obese patients--who undergoes bariatric surgery?